Development of anti-SARS-CoV-2 vaccines

Key facts

Disease
COVID-19
Funder
ANR
Principal Investigator
Véronique GODOT
Research Location
France
Lead Research Institution
Institut Mondor de Recherche Biomédicale - IMRB
Research Priority Alignment
N/A

Research Category
Vaccines research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract

The DC-CoVaC project, coordinated by Véronique Godot (UMR U955 Mondor Institute for Biomedical Research - IMRB), aims to test the immunogenicity and the preventive effect of a combination of two vaccine platforms in phase 1 to 3 of clinical development. Their approach aims to induce a polyepitopic T and B cell response. The vaccines will be tested in two preclinical models in order to study in vivo human immune responses induced by vaccines, and to demonstrate the protective effect of these vaccines.

Publicationslinked via Europe PMC

Last Updated:7 hours ago

View all publications at Europe PMC

Developing injury and illness epidemiology and surveillance in cycling (PhD Academy Award).

Effects of Hand-Rearing and Group Size on Chimpanzee (Pan troglodytes) Social Competence in Captivity.

Revisiting Spirituality in Physical Therapy Practice: Perceptions of US Practitioners.

Aflibercept for Wet Age-Related Macular Degeneration: A Prospective, Randomized Trial Comparing Treat-And-Extend and Fixed Bimonthly Dosing.

The Concentration and Duration of Lipopolysaccharide Stimulation Produce Different Cytokine Responses in an Ex Vivo Whole Blood Model in Horses.

History of Shrimp Farming and the Main Viral and Bacterial Diseases in Mexico.

Identification of Risk Factors in Patients with Recurrent Cystitis May Improve Individualized Management.

ISApl4, a New IS1595 Family Insertion Sequence Forming a Novel Pseudo-Compound Transposon That Confers Antimicrobial Multidrug Resistance in Actinobacillus pleuropneumoniae.